The promise and peril of gene drives
By Briefing,
The Economist
| 11. 08. 2018
“I think I got it,” says Alekos Simoni with a grin, returning an electronic fly zapper called “The Executioner” to a nearby metal shelf. With a deft flick of his wrist he has done away with a genetically modified mosquito that was making a bid for freedom. There are many levels of containment to ensure such creatures do not leave this basement laboratory at Imperial College, London. But none, perhaps, quite so satisfying as The Executioner.
The extermination that the creatures in Mr Simoni’s lab are designed to take part in is less viscerally gratifying—but far more consequential. The mosquitoes are being fitted with a piece of dnacalled a gene drive. Unlike the genes introduced into run-of-the-mill genetically modified organisms, gene drives do not just sit still once inserted into a chromosome. They actively spread themselves, thereby reaching more and more of the population with each generation. If their effect is damaging, they could in principle wipe out whole species.
To engineer an extinction is quite a step. But it is not unprecedented. In 1980 Variola, the smallpox...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...